
|Videos|October 20, 2021
AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs
Cate Lockhart, Pharm.D., Ph.D., spoke at AMCP Nexus about biosimilars, the insulin biosimilar Semglee and the role of PBMs.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
2
Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans
3
Vitiligo is associated with mental heath conditions, other autoimmune diseases
4
Make lab monitoring of patents taking isotretinoin less routine, more based on symptoms
5
































